Table 1.
BoHV-4 seroprevalence |
BoHV-1 seroprevalence |
||||
---|---|---|---|---|---|
Quebec samples (n = 100) | Ontario samples (n = 91) | Overall (n = 191) | Quebec samples (n = 100) | Ontario samples (n = 91) | Overall (n = 191) |
6.0% | 9.9% | 7.9% | 38.0% | 37.4% | 37.7% |
No significant statistical difference (P > 0.05) was observed between Quebec and Ontario seroprevalence for both BoHV-4 and BoHV-1 using the non-parametric Mann–Whitney test.